3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
12
Carcinoma, Renal Cell
11
Lymphoma
3
Neoplasms
2
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
2
Colorectal Neoplasms
2
Uveal Melanoma
1
Uterine Cervical Neoplasms
1
Triple Negative Breast Neoplasms
1
Thrombocythemia, Essential
1
Recurrence
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precancerous Conditions
1
Polycythemia Vera
1
Peritoneal Neoplasms
1
Pancreatic Neoplasms
1
Neuroendocrine Tumors
1
Neoplasm Metastasis
1
Myeloproliferative Disorders
1
Multiple Myeloma
1
Margins of Excision
1
Kidney Neoplasms
1
Hodgkin Disease
1
Hematologic Neoplasms
1
HTLV-I Infections
1
Carcinoma
1
Breast Neoplasms
1
Breast Carcinoma In Situ
1
Adenocarcinoma
1
Interventions
fludarabine phosphate
23
Cyclophosphamide
23
Whole-Body Irradiation
20
Mycophenolic Acid
17
Peripheral Blood Stem Cell Transplantation
15
Busulfan
14
Cyclosporine
12
Tacrolimus
10
Melphalan
10
Antilymphocyte Serum
9
Cord Blood Stem Cell Transplantation
7
Rituximab
6
Radiotherapy
6
Methotrexate
6
Filgrastim
6
Etoposide
6
fludarabine
5
Methylprednisolone
5
Granulocyte Colony-Stimulating Factor
4
Vincristine
3
Thiotepa
3
Sirolimus
3
Prednisone
3
Methylprednisolone Hemisuccinate
3
Methylprednisolone Acetate
3
Doxorubicin
3
Cytarabine
3
Carboplatin
3
Alemtuzumab
3
thymoglobulin
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Dendritic Cell Sarcoma, Interdigitating
×
Interferon alpha-2
×
Clear all
No trials found.